← Back to Clinical Trials
Recruiting NCT04753593

NCT04753593 Use of Discarded Surgery Human Tissue Specimens for Basic Science Research

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04753593
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Osteoblast
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2021-01-04
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2021-01-04 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Although it is now established that calcification process result from the joint and coordinated action of different cell types, many areas of shadow remain regarding the spatio-temporal implementation of these events. Highlighting these processes requires additional research to consider new approaches to clinical management of patients with such conditions. It is in this context that the investigators need to use residual human tissue fragments resulting from surgery which are not intended to be used for clinical-biological management of patients. The use of these pseudonymised human tissues will allow the investigators to conduct in vitro cell culture experiences.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing surgery in the Cardiac Surgery and Orthopedic Surgery departments of the CHU Amiens-Picardie * patients who will be beforehand informed * patients who will not be opposed to this study. Exclusion Criteria: * HIV and hepatitis positive patients

Contact & Investigator

Central Contact

Romuald Mentaverri, Pr

✉ romuald.mentaverri@u-picardie.fr

📞 03 22 887104

Frequently Asked Questions

Who can join the NCT04753593 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoblast. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04753593 currently recruiting?

Yes, NCT04753593 is actively recruiting participants. Contact the research team at romuald.mentaverri@u-picardie.fr for enrollment information.

Where is the NCT04753593 trial being conducted?

This trial is being conducted at Amiens, France.

Who is sponsoring the NCT04753593 clinical trial?

NCT04753593 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology